JPH1180145A - Production of propoxynitrobenzenes - Google Patents
Production of propoxynitrobenzenesInfo
- Publication number
- JPH1180145A JPH1180145A JP10205928A JP20592898A JPH1180145A JP H1180145 A JPH1180145 A JP H1180145A JP 10205928 A JP10205928 A JP 10205928A JP 20592898 A JP20592898 A JP 20592898A JP H1180145 A JPH1180145 A JP H1180145A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- cited
- group
- difluoro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Epoxy Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、合成抗菌薬の製造
中間体として有用な次の一般式(3)TECHNICAL FIELD The present invention relates to a compound represented by the following general formula (3) useful as an intermediate for producing a synthetic antibacterial drug:
【0002】[0002]
【化4】 Embedded image
【0003】(式中、X1 およびX2 は、各々独立に、
ハロゲン原子を示す)で表わされる2−オキシラニルメ
チルオキシ−3,4−ジハロゲノニトロベンゼンの製造
法に関する。Wherein X 1 and X 2 are each independently
A halogen atom), and a process for producing 2-oxiranylmethyloxy-3,4-dihalogenonitrobenzene.
【0004】[0004]
【従来の技術】オフロキサシン(OFLX)は優れた抗
菌活性と体内動態および高い安全性を有する合成抗菌剤
であり広く使用されている。また、その後の研究により
その光学活性体DR−3355は、ラセミ体であるオフ
ロキサシンよりさらに高い抗菌活性と安全性を有し、抗
菌剤としてより有用な化合物であることが明らかとなっ
た(特開昭57−46986号および特開昭62−25
2790号)。2. Description of the Related Art Ofloxacin (OFLX) is a synthetic antibacterial agent having excellent antibacterial activity, pharmacokinetics and high safety, and is widely used. Further, subsequent studies have revealed that the optically active form DR-3355 has a higher antibacterial activity and safety than racemic ofloxacin, and is a more useful compound as an antibacterial agent (Japanese Patent Application Laid-Open (JP-A) No. 9-110572). JP-A-57-46986 and JP-A-62-25
No. 2790).
【0005】[0005]
【発明が解決しようとする課題】そこで、本発明は上記
一般式(3)の化合物の工業的有利な製造法を提供すべ
く鋭意研究を行った結果、本発明を完成した。Accordingly, the present invention has been intensively studied to provide an industrially advantageous process for producing the compound of the general formula (3), and as a result, the present invention has been completed.
【0006】[0006]
【課題を解決するための手段】本発明は次の反応式で表
わされる。The present invention is represented by the following reaction formula.
【0007】[0007]
【化5】 Embedded image
【0008】(式中、X1 およびX2 は、各々独立に、
ハロゲン原子を示す) すなわち、本発明は、一般式(1)の化合物に式(2)
の化合物を反応させて一般式(3)の化合物を製造する
方法である。Wherein X 1 and X 2 are each independently
In other words, the present invention provides a compound of the general formula (1)
Is a method for producing a compound of the general formula (3) by reacting the compound of the formula (3).
【0009】[0009]
【発明の実施の形態】(2)式の化合物において、置換
スルホニルオキシ基としては、メタンスルホニルオキシ
基、トリフルオロメタンスルホニルオキシ基またはパラ
トルエンスルホニルオキシ基等が挙げられる。BEST MODE FOR CARRYING OUT THE INVENTION In the compound of formula (2), examples of the substituted sulfonyloxy group include a methanesulfonyloxy group, a trifluoromethanesulfonyloxy group and a paratoluenesulfonyloxy group.
【0010】化合物(1)と(2)との反応は塩基性条
件下に行われる。反応に使用する塩基としては水素化ナ
トリウム、水素化リチウム、ナトリウムアミド、水酸化
ナトリウム、水酸化カリウム、水酸化リチウム、炭酸カ
リウム、炭酸ナトリウム等の無機塩基、トリエチルアミ
ン、ジイソプロピルエチルアミン、1,8−ジアザビシ
クロ〔5,4,0〕−7−ウンデセン(DBU)、トリ
トンB等の有機塩基、tert−ブトキシカリウム、ナ
トリウムエトキサイド、ナトリウムメトキサイド等の金
属アルコキシド類、ブチルリチウム、フェニルリチウム
等のリチウム試薬を挙げることができ、これらは1〜1
0当量程度用いることが好ましい。The reaction between the compounds (1) and (2) is carried out under basic conditions. Examples of the base used in the reaction include inorganic bases such as sodium hydride, lithium hydride, sodium amide, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium carbonate, and sodium carbonate, triethylamine, diisopropylethylamine, 1,8-diazabicyclo. Organic bases such as [5,4,0] -7-undecene (DBU) and Triton B, metal alkoxides such as potassium tert-butoxide, sodium ethoxide and sodium methoxide, and lithium reagents such as butyllithium and phenyllithium. And these may be 1 to 1
It is preferable to use about 0 equivalent.
【0011】反応に使用する溶媒としてはベンゼン、ト
ルエン、キシレン、n−ヘキサン等の炭化水素系溶媒、
メタノール、エタノール、1−プロパノール、2−プロ
パノール、n−ブタノール等のアルコール系溶媒、ジエ
チルエーテル、テトラヒドロフラン、1,4−ジオキサ
ン、1,2−ジメトキシエタン等のエーテル系溶媒、ア
セトン、メチルエチルケトン等のケトン系溶媒、ジメチ
ルアセトアミド、ジメチルホルムアミド等のアミド系溶
媒、ジクロルメタン、ジクロルエタン、クロロホルム等
の塩素系溶媒、その他ジメチルスルホキシド、スルホラ
ン等を挙げることができる。Examples of the solvent used in the reaction include hydrocarbon solvents such as benzene, toluene, xylene and n-hexane;
Alcohol solvents such as methanol, ethanol, 1-propanol, 2-propanol and n-butanol; ether solvents such as diethyl ether, tetrahydrofuran, 1,4-dioxane and 1,2-dimethoxyethane; ketones such as acetone and methyl ethyl ketone Examples of the solvent include amide solvents such as dimethylacetamide and dimethylformamide, chlorine solvents such as dichloromethane, dichloroethane and chloroform, and dimethylsulfoxide and sulfolane.
【0012】反応は−78℃から溶媒の沸点の温度範囲
で実施することが好ましく、反応時間は約10分間から
数日であり、時に無水条件下で実施することが望ましい
ことがある。また、ヨウ化カリウム、ヨウ化ナトリウ
ム、クラウンエーテル等を1/100〜当量程度添加す
ると、これらの反応が促進されることがある。The reaction is preferably carried out in a temperature range from -78 ° C. to the boiling point of the solvent, the reaction time is from about 10 minutes to several days, and sometimes it may be desirable to carry out the reaction under anhydrous conditions. When potassium iodide, sodium iodide, crown ether, etc. are added in an amount of about 1/100 to equivalent, these reactions may be promoted.
【0013】原料の(2)式の化合物については、その
光学活性体を容易に入手することができ〔参考文献
J.Org.Chem.43,4876(1978)、
同52,3710(1986)、Angew.Che
m.Int.Ed.Engl.17,937(197
8)、Synthesis 316(1982)、J.
Org.Chem.46,3348(1981)、Ca
n.J.Chem.57,233(1979)〕、この
光学活性体を用いることにより(3)式で表わされる化
合物の光学活性体を得ることができる。As for the compound of the formula (2) as a raw material, its optically active substance can be easily obtained [References]
J. Org. Chem. 43 , 4876 (1978),
52 , 3710 (1986), Angew. Che
m. Int. Ed. Engl. 17 , 937 (197)
8), Synthesis 316 (1982);
Org. Chem. 46 , 3348 (1981), Ca
n. J. Chem. 57, 233 (1979)]. By using this optically active substance, an optically active substance of the compound represented by the formula (3) can be obtained.
【0014】[0014]
【実施例】次に実施例を挙げて説明する。Next, an embodiment will be described.
【0015】実施例12,3−ジフルオロ−6−ニトロ−〔(R)−2,3−
エポキシプロピルオキシ〕ベンゼン((3):X1=X2
=F) 2,3−ジフルオロ−6−ニトロフェノール((1):
X1=X2=F)700.4mgを無水DMF4mlに溶解
後、K2CO3 304.1mgを加え70℃で30分間攪
拌する。触媒量の18−クラウン−6−エーテル、KI
242.4mgおよび(R)−グリシジルトシレート1
gを加え同温で6時間加熱攪拌する。反応後、酢酸エチ
ルを加え有機層を水洗、乾燥(MgSO4)後、留去し
て得た残渣をシリカゲルカラムクロマトグラフィに付
し、ベンゼン流分より油状物質として標記の縮合体50
7mg、収率55%を得た。 NMR(CDCl3)δ: 2.72(1H,d,d,J=2.7 and 4.8Hz,エポキシプロピル基3位
のプロトン) 2.89(1H,d,d,J=4.8 and 4.8Hz,エポキシプロピル基3位
のプロトン) 3.42(1H,巾18Hzの多重線,エポキシプロピル基2位のメ
チレンプロトン) 4.21(1H,d,d,d,J=1.2,6.0 and 7.2Hz,エポキシプロピル
基1位のプロトン) 4.53(1H,d,d,d,J=1.2,3.6 and 4.8Hz,エポキシプロピル
基1位のプロトン) 7.07(1H,d,d,d,J=7.2,9.0 and 9.6Hz,4位核プロトン) 7.74(1H,d,d,d,J=2.4,5.4 and 7.2Hz,5位核プロトン)Example 1 2,3-difluoro-6-nitro-[(R) -2,3-
Epoxypropyloxy] benzene ((3): X 1 = X 2
= F) 2,3-difluoro-6-nitrophenol ((1):
After dissolving 700.4 mg of (X 1 = X 2 = F) in 4 ml of anhydrous DMF, add 304.1 mg of K 2 CO 3 and stir at 70 ° C. for 30 minutes. Catalytic amount of 18-crown-6-ether, KI
242.4 mg and (R) -glycidyl tosylate 1
g, and the mixture is heated and stirred at the same temperature for 6 hours. After the reaction, ethyl acetate was added, and the organic layer was washed with water, dried (MgSO 4 ), and evaporated, and the residue obtained was subjected to silica gel column chromatography.
7 mg, yield 55%. NMR (CDCl 3 ) δ: 2.72 (1H, d, d, J = 2.7 and 4.8 Hz, proton at the 3rd position of the epoxypropyl group) 2.89 (1H, d, d, J = 4.8 and 4.8 Hz, 3rd position of the epoxypropyl group) 3.42 (1H, multiple line with 18 Hz width, methylene proton at the 2nd position of epoxypropyl group) 4.21 (1H, d, d, d, J = 1.2, 6.0 and 7.2 Hz, proton at the 1st position of epoxypropyl group) 4.53 (1H, d, d, d, J = 1.2,3.6 and 4.8Hz, 1st position of epoxypropyl group proton) 7.07 (1H, d, d, d, J = 7.2,9.0 and 9.6Hz, 4th position proton) 7.74 (1H, d, d, d, J = 2.4,5.4 and 7.2Hz, 5-position proton)
【0016】[0016]
【発明の効果】本発明方法によれば、合成抗菌薬の製造
中間体として有用な一般式(3)の化合物を高収率で得
ることができる。According to the method of the present invention, a compound of the general formula (3) useful as an intermediate for producing a synthetic antibacterial drug can be obtained in high yield.
Claims (3)
を示す)で表わされる化合物に、式(2) 【化2】 で表わされる化合物を反応させることを特徴とする一般
式(3) 【化3】 (式中、X1 およびX2 は、各々独立に、ハロゲン原子
を示す)で表わされる化合物の製造法。1. A compound of the general formula (1) Wherein X 1 and X 2 each independently represent a halogen atom, to a compound represented by the formula (2): Wherein the compound represented by the general formula (3) is reacted: (Wherein X 1 and X 2 each independently represent a halogen atom).
ホニルオキシ基、トリフルオロメタンスルホニルオキシ
基またはパラトルエンスルホニルオキシ基である請求項
1記載の製造法。2. The method according to claim 1, wherein the substituted sulfonyloxy group is a methanesulfonyloxy group, a trifluoromethanesulfonyloxy group or a paratoluenesulfonyloxy group.
る請求項1又は請求項2記載の製造法。3. The method according to claim 1, wherein X 1 and X 2 are each a fluorine atom.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10205928A JP3002978B2 (en) | 1998-07-22 | 1998-07-22 | Method for producing propoxynitrobenzenes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10205928A JP3002978B2 (en) | 1998-07-22 | 1998-07-22 | Method for producing propoxynitrobenzenes |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1037989A Division JP2857760B2 (en) | 1989-02-17 | 1989-02-17 | Production method of propoxynitrobenzenes |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH1180145A true JPH1180145A (en) | 1999-03-26 |
JP3002978B2 JP3002978B2 (en) | 2000-01-24 |
Family
ID=16515069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10205928A Expired - Lifetime JP3002978B2 (en) | 1998-07-22 | 1998-07-22 | Method for producing propoxynitrobenzenes |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3002978B2 (en) |
-
1998
- 1998-07-22 JP JP10205928A patent/JP3002978B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP3002978B2 (en) | 2000-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116987112A (en) | Improved process for preparing aminopyrimidine derivatives | |
TW201028374A (en) | Method of preparing ezetimibe and intermediates used therein | |
US6407255B2 (en) | Chemical synthesis of 1,2,4-triazolinone derivative | |
EP2401253B1 (en) | A process for the preparation of etoricoxib | |
US6538134B2 (en) | 4-Benzyl-2-hydroxy-1,4-oxazine-3-one and polymorphic forms thereof | |
JP3002978B2 (en) | Method for producing propoxynitrobenzenes | |
JP7292517B2 (en) | Process and intermediates for the preparation of oxetan-2-ylmethanamine | |
CN107382892A (en) | A kind of preparation technology of the nitro isoxazole compound of 3 aryl 4 | |
JPH061776A (en) | Production of substituted pyrazinecarbonitrile | |
JPH02289563A (en) | Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones | |
JP3810858B2 (en) | Process for producing 4-trifluoromethylnicotinic acid | |
CN112135820B (en) | Novel process for preparing diaminopyrimidine derivatives or acid addition salts thereof | |
JP3066594B2 (en) | Aniline derivative and method for producing the same | |
JPWO2002076958A1 (en) | Method for producing 5-substituted oxazole compound and 5-substituted imidazole compound | |
JP3596041B2 (en) | O-alkyl-N- (β-nitroethyl) hydroxylamine derivative and method for producing the same | |
KR100374405B1 (en) | A new process for amlodipine besylate | |
JPH0665213A (en) | Dicyanopyrazine derivative and its production | |
JP3919251B2 (en) | Dicyanopyrazine derivative and method for producing the same | |
EP0726897A1 (en) | Process for the preparation of n-4- (substituted phenyl)alkylthienyl]-, and n-4- (substituted phenyl)alkylfuryl]but-3-yn-2-yl]-n-hydroxyurea compounds | |
JPH0368546A (en) | Preparation of substituted glycine derivative | |
JP2005281168A (en) | Method for producing 3-pyrrolidinol | |
JP3981996B2 (en) | Ketooxazolidinone and process for producing amidoindanol from the compound | |
JPH0867677A (en) | Production of amine compound | |
JPH03232871A (en) | Production of benzoxazine derivative | |
JP2008273841A (en) | Ethylenediamine derivative and process for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081119 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081119 Year of fee payment: 9 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313111 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081119 Year of fee payment: 9 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081119 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091119 Year of fee payment: 10 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091119 Year of fee payment: 10 |